U.S. RESEARCH ROUNDUP-Avexis, Burlington Stores, Prologis

Bellicum Pharmaceuticals

12/04/2018 08:10

April 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Avexis, Burlington Stores and Prologis, on Thursday.
    
    HIGHLIGHTS
     * Avexis Inc  AVXS.O : Barclays cuts to equal weight from overweight
     * Burlington Stores Inc  BURL.N : Morgan Stanley raises price target to $145 from $132
     * Prologis Inc  PLD.N : Jefferies raises to buy from hold
        
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order. 
    
    

     * Aetna Inc  AET.N : Jefferies cuts price target to $193
     * Avexis Inc  AVXS.O : Barclays cuts to equal weight from overweight
     * Avexis Inc  AVXS.O : Barclays raises price target to $218 from $152
     * Bed Bath & Beyond Inc  BBBY.O : Credit Suisse cuts price target to $20 from $25
     * Bed Bath & Beyond Inc  BBBY.O : Keybanc cuts price target to $16 from $17
     * Bed Bath & Beyond Inc  BBBY.O : Morgan Stanley cuts price target to $16 from $20
     * Bellicum Pharmaceuticals  BLCM.O : SunTrust Robinson raises price target to $23 from $18
     * Burlington Stores Inc  BURL.N : Morgan Stanley raises price target to $145 from $132
     * Estee Lauder Companies Inc  EL.N : Oppenheimer raises price target to $170 from $148
     * Humana Inc  HUM.N : Jefferies raises price target to $356
     * O'Reilly Automotive Inc  ORLY.O : Credit Suisse cuts price target to $246 from $264
     * Penn Virginia Corp  PVAC.O : SunTrust Robinson raises price target to $60 from $55
     * Prologis Inc  PLD.N : Jefferies raises price target to $73 from $70
     * Prologis Inc  PLD.N : Jefferies raises to buy from hold
     * Splunk Inc  SPLK.O : Credit Suisse raises price target to $115 from $110
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))